Oncotarget

Research Papers:

Doxorubicin-fucoidan-gold nanoparticles composite for dualchemo-photothermal treatment on eye tumors

Hyejin Kim, Van Phuc Nguyen, Panchanathan Manivasagan, Min Jung Jung, Sung Won Kim _, Junghwan Oh and Hyun Wook Kang

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:113719-113733. https://doi.org/10.18632/oncotarget.23092

Metrics: PDF 1255 views  |   HTML 2956 views  |   ?  


Abstract

Hyejin Kim1,*, Van Phuc Nguyen1,*, Panchanathan Manivasagan2,*, Min Jung Jung3, Sung Won Kim4, Junghwan Oh1,2 and Hyun Wook Kang1,2

1Interdisciplinary Program of Biomedical Mechanical and Electrical Engineering, Pukyong National University, Busan, South Korea

2Department of Biomedical Engineering and Center for Marine-Integrated Biomedical Technology (BK 21 Plus), Pukyong National University, Busan, South Korea

3Department of Pathology, Kosin University College of Medicine, Busan, South Korea

4Department of Otolaryngology-Head and Neck Surgery, Kosin University College of Medicine, Busan, South Korea

*These authors contributed equally to this work

Correspondence to:

Sung Won Kim, email: swforyou@gmail.com

Junghwan Oh, email: jungoh@pknu.ac.kr

Hyun Wook Kang, email: wkang@pukyong.ac.kr

Keywords: doxorubicin; gold-nanoparticles; photothermal therapy; chemotherapy; eye tumor

Received: October 16, 2017     Accepted: December 01, 2017     Published: December 09, 2017

ABSTRACT

The current research demonstrates the feasible biomedical application of AuNPs coated with doxorubicin (Dox)-loaded fucoidan (Fu) for dual-chemotherapy and photothermal treatment (PTT) on eye tumors in vitro and in vivo. Marine-derived Fu was used as a capping agent to achieve high photostability for AuNPs, and Dox as a FDA-approved anti-cancer drug was added to induce chemotherapy. The synthesized Dox-Fu@AuNPs exhibited high cytotoxicity on the tumor cells and strong light absorption for temperature increase in vitro. After intratumoral injection of Dox-Fu@AuNPs in the rabbit eye tumors, PTT-assisted Dox-Fu@AuNPs entailed the complete removal of the eye tumors without recurrence for 14 days after the treatment. Photoacoustic image contrast from the tumor regions was enhanced due to selective light absorption by the administered Dox-Fu@AuNPs. Therefore, the proposed Dox-Fu@AuNPs can be a potential nano-theranostic material for treating and diagnosing the eye tumors.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 23092